Flux Power(FLUX) - 2026 Q2 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Revenue for Q2 2026 was $14.1 million, an increase from $13.2 million in the prior quarter but a decrease from $16.8 million in the same quarter last year [16] - Gross margin improved to 34.7% from 28.6% in the prior quarter and 32.5% in the same quarter last year, reflecting a 610 basis point sequential increase due to improved product mix and cost-saving initiatives [16] - Operating expenses decreased to $4.1 million from $5.9 million in the prior quarter and $6.9 million in the same quarter last year, a 31% sequential decrease [17] - Net income for Q2 was $0.6 million, or $0.03 per share, compared to a net loss of $2.6 million in the prior quarter and a net loss of $1.9 million in the same quarter last year [17] - Adjusted EBITDA was positive $1.5 million, compared to a loss of $1.4 million in the prior quarter and positive $130,000 in the same quarter a year ago [18] Business Line Data and Key Metrics Changes - The company achieved net profitability for the first time in its history, attributed to expense optimization and sequential revenue growth [4][5] - The introduction of the SkyLink telematics device is expected to enhance product offerings and customer engagement, with positive feedback from beta tests [9][10] Market Data and Key Metrics Changes - The lithium-ion forklift battery segment is projected to grow at an 8.8% CAGR through 2035, indicating strong long-term market opportunities [15] - The company is experiencing a capital freeze from its most significant customer, which may impact revenue for a significant portion of calendar year 2026 [14] Company Strategy and Development Direction - The company is focused on five strategic initiatives: profitable growth, operational efficiencies, solution selling, building the right products, and integrating value-added software [5] - The company is enhancing its product line and energy system software using AI to improve operational efficiencies and customer solutions [20] Management's Comments on Operating Environment and Future Outlook - Management noted that while the business is performing well, the capital freeze from a major customer may lead to materially lower revenue in the third quarter [14] - Despite short-term market pressures, management remains optimistic about the long-term growth potential in the lithium-ion battery market [15] Other Important Information - The company has implemented AI-driven tools in engineering design and operations to further improve efficiencies [7] - A new GAT 315 battery was released in response to customer demand, expanding the product line for the GSE segment [10] Q&A Session Summary Question: Is the capital freeze unique to one customer or seen across the industry? - Management confirmed that the capital freeze is specific to one individual customer [23] Question: How is the overall demand environment looking? - Management indicated that while there are lingering tariff effects, customers still need to purchase batteries to operate their businesses [24] Question: What is the rollout strategy for the SkyLink product? - The SkyLink telematics will be offered across the product line, with initial positive feedback from customers [25][26] Question: Will cost savings and warranty costs remain low to improve gross margins? - Management expects continued positive trends in warranty and repair costs, but gross margins may vary based on product mix [30][31] Question: What is the strategy for filling the revenue gap from the capital freeze? - The company is actively hiring new sales personnel and focusing on increasing adoption of lithium batteries [36] Question: Will new SkyLink features be sold at a premium? - Management plans to offer a standard and a premium version of the software, with higher gross margins expected from premium sales [39] Question: Can you elaborate on the State of Health patent and its revenue potential? - The patent includes algorithms for battery health insights, which will be part of a premium software package aimed at generating revenue [42]